Table 2 Analysis of vitals and clinical data between groups.

Systolic BP (mmHg)

188 (182–199)

190 (185–200)

0.321^m

Diastolic BP (mmHg)

109 (100–110)

105 (100–115)

0.765^m

End systolic BP

157.0 ± 9.8

170.6 ± 6.7

< 0.001^†

End diastolic BP

83.7 ± 5.2

91.5 ± 5.3

< 0.001^†

BP control time (min)

19.0 ± 6.35

25.4 ± 8.7

< 0.001^†

Pulse

80 (76–90)

87 (80–97)

0.047^m

Tempereture ( C)

36.7 (36.7–36.9)

36.8 (36.7–36.9)

0.418^m

Breathing (/min)

14 (13–16)

15 (14–18)

0.157^m

Saturation

98 (96–99)

96 (96–99)

0.256^m

NIHSS at admission

10.5 ± 5.9

12.8 ± 7.5

0.131^†

Symptom door duration (min)

63.1 ± 37.1

79.2 ± 42.0

0.070^†

Symptom needle Dur. (min)

160.5 ± 58.1

174.8 ± 48.2

0.228^†

Door needle duration (min)

97.4 ± 56.2

95.6 ± 41.04

0.866^†

Hospitalisation (day)

11 (7–21)

10 (7–16)

0.375^m

mRS

3 (1–6)

3 (1–6)

0.691^m

ICH (+) n(%)

14 (35%)

12 (28.6%)

0.698 ^χ2

Mortality (+) n(%)

13 (32.5%)

12 (28.6%)

0.699 ^χ2